Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09NAW
|
|||
Former ID |
DIB001866
|
|||
Drug Name |
PF-05105679
|
|||
Indication | Pain [ICD-11: MG30-MG3Z] | Phase 1 | [1] | |
Company |
Pfizer Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H21FN2O3
|
|||
Canonical SMILES |
CC(C1=CC=C(C=C1)F)N(CC2=CC(=CC=C2)C(=O)O)C(=O)C3=CC4=CC=CC=C4N=C3
|
|||
InChI |
1S/C26H21FN2O3/c1-17(19-9-11-23(27)12-10-19)29(16-18-5-4-7-21(13-18)26(31)32)25(30)22-14-20-6-2-3-8-24(20)28-15-22/h2-15,17H,16H2,1H3,(H,31,32)/t17-/m1/s1
|
|||
InChIKey |
BXNMZRPTQFVRFA-QGZVFWFLSA-N
|
|||
CAS Number |
CAS 1398583-31-7
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Long transient receptor potential channel 8 (TRPM8) | Target Info | Modulator | [1] |
KEGG Pathway | Inflammatory mediator regulation of TRP channels | |||
Reactome | TRP channels |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans. J Pharmacol Exp Ther. 2014 Nov;351(2):259-69. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.